{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:53:26Z","timestamp":1794574406344,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1976\/20"],"award-info":[{"award-number":["1976\/20"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001738","name":"Ministry of Science, Technology and Space","doi-asserted-by":"publisher","award":["5100"],"award-info":[{"award-number":["5100"]}],"id":[{"id":"10.13039\/501100001738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epilepsy affects over 65 million people worldwide and significantly burdens patients, caregivers, and society. Drug-resistant epilepsy occurs in approximately 30% of patients and growing evidence indicates that oxidative stress contributes to the development of such epilepsies. Activation of the Nrf2 pathway, which is involved in cellular defense, offers a potential strategy for reducing oxidative stress and epilepsy treatment. Dimethyl fumarate (DMF), an Nrf2 activator, exhibits antioxidant and anti-inflammatory effects and is used to treat multiple sclerosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The expression of Nrf2 and its related genes in vehicle or DMF treated rats were determined via RT-PCR and Western blot analysis. Neuronal cell death was evaluated by immunohistochemical staining. The effects of DMF in preventing the onset of epilepsy and modifying the disease were investigated in the kainic acid-induced status epilepticus model of temporal lobe epilepsy in rats.<\/jats:p>\n                    <jats:p>The open field, elevated plus maze and T-Maze spontaneous alteration tests were used for behavioral assessments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We demonstrate that administration of DMF following status epilepticus increased Nrf2 activity, attenuated status epilepticus-induced neuronal cell death, and decreased seizure frequency and the total number of seizures compared to vehicle-treated animals. Moreover, DMF treatment reversed epilepsy-induced behavioral deficits in the treated rats.<\/jats:p>\n                    <jats:p>Moreover, DMF treatment even when initiated well after the diagnosis of epilepsy, reduced symptomatic seizures long after the drug was eliminated from the body.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Taken together, these findings suggest that DMF, through the activation of Nrf2, has the potential to serve as a therapeutic target for preventing epileptogenesis and modifying epilepsy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04695-2","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T12:02:03Z","timestamp":1699444923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Repurposing dimethyl fumarate as an antiepileptogenic and disease-modifying treatment for drug-resistant epilepsy"],"prefix":"10.1186","volume":"21","author":[{"given":"Sereen","family":"Sandouka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-2435","authenticated-orcid":false,"given":"Prince Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Saadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoda Olowe","family":"Taiwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Sheeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taige","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larin","family":"Deeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Guignet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve H.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6165-2219","authenticated-orcid":false,"given":"Tawfeeq","family":"Shekh-Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"issue":"21","key":"4695_CR1","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1523\/JNEUROSCI.0066-09.2009","volume":"29","author":"LH Zeng","year":"2009","unstructured":"Zeng LH, Rensing NR, Wong M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J Neurosci. 2009;29(21):6964\u201372.","journal-title":"J Neurosci"},{"key":"4695_CR2","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","volume":"4","author":"O Devinsky","year":"2018","unstructured":"Devinsky O, Vezzani A, O\u2019Brien TJ, Jette N, Scheffer IE, de Curtis M, et al. Epilepsy. Nat Rev Dis Primers. 2018;4:18024.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"4695_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1212\/WNL.0000000000002253","volume":"86","author":"O Devinsky","year":"2016","unstructured":"Devinsky O, Spruill T, Thurman D, Friedman D. Recognizing and preventing epilepsy-related mortality: a call for action. Neurology. 2016;86(8):779\u201386.","journal-title":"Neurology"},{"key":"4695_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.seizure.2018.12.007","volume":"64","author":"TA Manolis","year":"2019","unstructured":"Manolis TA, Manolis AA, Melita H, Manolis AS. Sudden unexpected death in epilepsy: the neuro-cardio-respiratory connection. Seizure. 2019;64:65\u201373.","journal-title":"Seizure"},{"issue":"3","key":"4695_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","volume":"75","author":"Z Chen","year":"2018","unstructured":"Chen Z, Brodie MJ, Liew D, Kwan P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018;75(3):279\u201386.","journal-title":"JAMA Neurol"},{"key":"4695_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.seizure.2016.11.022","volume":"44","author":"A Golyala","year":"2017","unstructured":"Golyala A, Kwan P. Drug development for refractory epilepsy: the past 25 years and beyond. Seizure. 2017;44:147\u201356.","journal-title":"Seizure"},{"issue":"1","key":"4695_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13024-017-0163-2","volume":"12","author":"T Engel","year":"2017","unstructured":"Engel T, Martinez-Villarreal J, Henke C, Jimenez-Mateos EM, Sanz-Rodriguez A, Alves M, et al. Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury. Mol Neurodegener. 2017;12(1):21.","journal-title":"Mol Neurodegener"},{"key":"4695_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yebeh.2014.05.031","volume":"37","author":"KD Laxer","year":"2014","unstructured":"Laxer KD, Trinka E, Hirsch LJ, Cendes F, Langfitt J, Delanty N, et al. The consequences of refractory epilepsy and its treatment. Epilepsy Behav. 2014;37:59\u201370.","journal-title":"Epilepsy Behav"},{"issue":"5","key":"4695_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.5694\/mja17.00951","volume":"208","author":"P Perucca","year":"2018","unstructured":"Perucca P, Scheffer IE, Kiley M. The management of epilepsy in children and adults. Med J Aust. 2018;208(5):226\u201333.","journal-title":"Med J Aust"},{"key":"4695_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.674483","volume":"12","author":"A Fattorusso","year":"2021","unstructured":"Fattorusso A, Matricardi S, Mencaroni E, Dell\u2019Isola GB, Di Cara G, Striano P, et al. The pharmacoresistant epilepsy: an overview on existant and new emerging therapies. Front Neurol. 2021;12: 674483.","journal-title":"Front Neurol"},{"issue":"1","key":"4695_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.eplepsyres.2005.09.014","volume":"68","author":"MA Dichter","year":"2006","unstructured":"Dichter MA. Models of epileptogenesis in adult animals available for antiepileptogenesis drug screening. Epilepsy Res. 2006;68(1):31\u20135.","journal-title":"Epilepsy Res"},{"issue":"4","key":"4695_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1124\/pr.110.003046","volume":"62","author":"W L\u00f6scher","year":"2010","unstructured":"L\u00f6scher W, Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev. 2010;62(4):668\u2013700.","journal-title":"Pharmacol Rev"},{"key":"4695_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102463","volume":"28","author":"JE Peixoto-Santos","year":"2020","unstructured":"Peixoto-Santos JE, Velasco TR, Carlotti CG, Assirati JA, Rezende G, Kobow K, et al. Histological correlates of hippocampal magnetization transfer images in drug-resistant temporal lobe epilepsy patients. Neuroimage Clin. 2020;28: 102463.","journal-title":"Neuroimage Clin"},{"issue":"5","key":"4695_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/nan.12150","volume":"40","author":"M Thom","year":"2014","unstructured":"Thom M. Review: hippocampal sclerosis in epilepsy: a neuropathology review. Neuropathol Appl Neurobiol. 2014;40(5):520\u201343.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"4695_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/nan.12087","volume":"40","author":"R Bandopadhyay","year":"2014","unstructured":"Bandopadhyay R, Liu JY, Sisodiya SM, Thom M. A comparative study of the dentate gyrus in hippocampal sclerosis in epilepsy and dementia. Neuropathol Appl Neurobiol. 2014;40(2):177\u201390.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"4695_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9(1):42.","journal-title":"Transl Neurodegener"},{"issue":"3","key":"4695_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/antiox6030065","volume":"6","author":"JR Liddell","year":"2017","unstructured":"Liddell JR. Are astrocytes the predominant cell type for activation of Nrf2 in aging and neurodegeneration? Antioxidants (Basel). 2017;6(3):65.","journal-title":"Antioxidants (Basel)."},{"issue":"1","key":"4695_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","volume":"58","author":"J Emerit","year":"2004","unstructured":"Emerit J, Edeas M, Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother. 2004;58(1):39\u201346.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"4695_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrd1330","volume":"3","author":"KJ Barnham","year":"2004","unstructured":"Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov. 2004;3(3):205\u201314.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"4695_CR20","doi-asserted-by":"publisher","first-page":"18348","DOI":"10.3390\/ijms160818348","volume":"16","author":"L Carmona-Aparicio","year":"2015","unstructured":"Carmona-Aparicio L, Perez-Cruz C, Zavala-Tecuapetla C, Granados-Rojas L, Rivera-Espinosa L, Montesinos-Correa H, et al. Overview of Nrf2 as therapeutic target in epilepsy. Int J Mol Sci. 2015;16(8):18348\u201367.","journal-title":"Int J Mol Sci"},{"issue":"13","key":"4695_CR21","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1089\/neu.2013.3218","volume":"31","author":"DM Miller","year":"2014","unstructured":"Miller DM, Wang JA, Buchanan AK, Hall ED. Temporal and spatial dynamics of nrf2-antioxidant response elements mediated gene targets in cortex and hippocampus after controlled cortical impact traumatic brain injury in mice. J Neurotrauma. 2014;31(13):1194\u2013201.","journal-title":"J Neurotrauma"},{"issue":"4","key":"4695_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","volume":"18","author":"A Cuadrado","year":"2019","unstructured":"Cuadrado A, Rojo AI, Wells G, Hayes JD, Cousin SP, Rumsey WL, et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 2019;18(4):295\u2013317.","journal-title":"Nat Rev Drug Discov"},{"key":"4695_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fphar.2019.00382","volume":"10","author":"RM da Costa","year":"2019","unstructured":"da Costa RM, Rodrigues D, Pereira CA, Silva JF, Alves JV, Lobato NS, et al. Nrf2 as a potential mediator of cardiovascular risk in metabolic diseases. Front Pharmacol. 2019;10:382.","journal-title":"Front Pharmacol"},{"issue":"11","key":"4695_CR24","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3390\/antiox10111702","volume":"10","author":"S Sandouka","year":"2021","unstructured":"Sandouka S, Shekh-Ahmad T. Induction of the Nrf2 pathway by sulforaphane is neuroprotective in a rat temporal lobe epilepsy model. Antioxidants (Basel). 2021;10(11):1702.","journal-title":"Antioxidants (Basel)."},{"issue":"44","key":"4695_CR25","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1523\/JNEUROSCI.1304-15.2015","volume":"35","author":"J Tu","year":"2015","unstructured":"Tu J, Zhang X, Zhu Y, Dai Y, Li N, Yang F, et al. Cell-permeable peptide targeting the Nrf2-Keap1 interaction: a potential novel therapy for global cerebral ischemia. J Neurosci. 2015;35(44):14727\u201339.","journal-title":"J Neurosci"},{"issue":"6","key":"4695_CR26","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1111\/j.1471-4159.2006.04019.x","volume":"98","author":"AD Kraft","year":"2006","unstructured":"Kraft AD, Lee JM, Johnson DA, Kan YW, Johnson JA. Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element. J Neurochem. 2006;98(6):1852\u201365.","journal-title":"J Neurochem"},{"key":"4695_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neulet.2013.03.038","volume":"543","author":"W Wang","year":"2013","unstructured":"Wang W, Wang WP, Zhang GL, Wu YF, Xie T, Kan MC, et al. Activation of Nrf2-ARE signal pathway in hippocampus of amygdala kindling rats. Neurosci Lett. 2013;543:58\u201363.","journal-title":"Neurosci Lett"},{"issue":"5","key":"4695_CR28","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/med.21567","volume":"39","author":"NEB Saidu","year":"2019","unstructured":"Saidu NEB, Kavian N, Leroy K, Jacob C, Nicco C, Batteux F, et al. Dimethyl fumarate, a two-edged drug: current status and future directions. Med Res Rev. 2019;39(5):1923\u201352.","journal-title":"Med Res Rev"},{"key":"4695_CR29","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fimmu.2016.00278","volume":"7","author":"Z Al-Jaderi","year":"2016","unstructured":"Al-Jaderi Z, Maghazachi AA. Utilization of dimethyl fumarate and related molecules for treatment of multiple sclerosis, cancer, and other diseases. Front Immunol. 2016;7:278.","journal-title":"Front Immunol"},{"issue":"7","key":"4695_CR30","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1161\/STROKEAHA.115.009398","volume":"46","author":"X Zhao","year":"2015","unstructured":"Zhao X, Sun G, Zhang J, Ting SM, Gonzales N, Aronowski J. Dimethyl fumarate protects brain from damage produced by intracerebral hemorrhage by mechanism involving Nrf2. Stroke. 2015;46(7):1923\u20138.","journal-title":"Stroke"},{"issue":"1","key":"4695_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1124\/jpet.111.190132","volume":"341","author":"RH Scannevin","year":"2012","unstructured":"Scannevin RH, Chollate S, Jung MY, Shackett M, Patel H, Bista P, et al. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway. J Pharmacol Exp Ther. 2012;341(1):274\u201384.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"4695_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120254","volume":"10","author":"MS Brennan","year":"2015","unstructured":"Brennan MS, Matos MF, Li B, Hronowski X, Gao B, Juhasz P, et al. Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro. PLoS ONE. 2015;10(3): e0120254.","journal-title":"PLoS ONE"},{"issue":"1","key":"4695_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0920-1211(98)00017-5","volume":"31","author":"JL Hellier","year":"1998","unstructured":"Hellier JL, Patrylo PR, Buckmaster PS, Dudek FE. Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res. 1998;31(1):73\u201384.","journal-title":"Epilepsy Res"},{"issue":"5","key":"4695_CR34","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/brain\/awy071","volume":"141","author":"T Shekh-Ahmad","year":"2018","unstructured":"Shekh-Ahmad T, Eckel R, Dayalan Naidu S, Higgins M, Yamamoto M, Dinkova-Kostova AT, et al. KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy. Brain. 2018;141(5):1390\u2013403.","journal-title":"Brain"},{"issue":"2","key":"4695_CR35","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0306-4522(85)90299-4","volume":"14","author":"Y Ben-Ari","year":"1985","unstructured":"Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 1985;14(2):375\u2013403.","journal-title":"Neuroscience"},{"key":"4695_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101278","volume":"26","author":"T Shekh-Ahmad","year":"2019","unstructured":"Shekh-Ahmad T, Lieb A, Kovac S, Gola L, Christian Wigley W, Abramov AY, et al. Combination antioxidant therapy prevents epileptogenesis and modifies chronic epilepsy. Redox Biol. 2019;26: 101278.","journal-title":"Redox Biol"},{"issue":"4","key":"4695_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"1","key":"4695_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13578-022-00951-y","volume":"13","author":"S Sandouka","year":"2023","unstructured":"Sandouka S, Saadi A, Singh PK, Olowe R, Shekh-Ahmad T. Nrf2 is predominantly expressed in hippocampal neurons in a rat model of temporal lobe epilepsy. Cell Biosci. 2023;13(1):3.","journal-title":"Cell Biosci"},{"issue":"1","key":"4695_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0006-8993(00)02137-5","volume":"864","author":"KJ Hopkins","year":"2000","unstructured":"Hopkins KJ, Wang G, Schmued LC. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res. 2000;864(1):69\u201380.","journal-title":"Brain Res"},{"issue":"7","key":"4695_CR40","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/j.1528-1167.2012.03525.x","volume":"53","author":"B Jupp","year":"2012","unstructured":"Jupp B, Williams J, Binns D, Hicks RJ, Cardamone L, Jones N, et al. Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE. Epilepsia. 2012;53(7):1233\u201344.","journal-title":"Epilepsia"},{"issue":"1","key":"4695_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084722","volume":"9","author":"GH Maia","year":"2014","unstructured":"Maia GH, Quesado JL, Soares JI, Carmo do JM, Andrade PA, Andrade JP, et al. Loss of hippocampal neurons after kainate treatment correlates with behavioral deficits. PLoS ONE. 2014;9(1): e84722.","journal-title":"PLoS ONE."},{"key":"4695_CR42","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3389\/fneur.2017.00588","volume":"8","author":"D Bertoglio","year":"2017","unstructured":"Bertoglio D, Amhaoul H, Van Eetveldt A, Houbrechts R, Van De Vijver S, Ali I, et al. Kainic acid-induced post-status epilepticus models of temporal lobe epilepsy with diverging seizure phenotype and neuropathology. Front Neurol. 2017;8:588.","journal-title":"Front Neurol"},{"issue":"11","key":"4695_CR43","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1111\/j.1528-1167.2008.01666.x","volume":"49","author":"G Gong","year":"2008","unstructured":"Gong G, Shi F, Concha L, Beaulieu C, Gross DW. Insights into the sequence of structural consequences of convulsive status epilepticus: a longitudinal MRI study. Epilepsia. 2008;49(11):1941\u20135.","journal-title":"Epilepsia"},{"issue":"3","key":"4695_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.seizure.2010.01.010","volume":"19","author":"J Liu","year":"2010","unstructured":"Liu J, Wang A, Li L, Huang Y, Xue P, Hao A. Oxidative stress mediates hippocampal neuron death in rats after lithium-pilocarpine-induced status epilepticus. Seizure. 2010;19(3):165\u201372.","journal-title":"Seizure"},{"key":"4695_CR45","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2019.02.031","volume":"1715","author":"A Wang","year":"2019","unstructured":"Wang A, Si Z, Xue P, Li X, Liu J. Tacrolimus protects hippocampal neurons of rats with status epilepticus through suppressing oxidative stress and inhibiting mitochondrial pathway of apoptosis. Brain Res. 2019;1715:176\u201381.","journal-title":"Brain Res"},{"issue":"11","key":"4695_CR46","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3390\/antiox9111029","volume":"9","author":"TK Lin","year":"2020","unstructured":"Lin TK, Chen SD, Lin KJ, Chuang YC. Seizure-induced oxidative stress in status epilepticus: is antioxidant beneficial? Antioxidants (Basel). 2020;9(11):1029.","journal-title":"Antioxidants (Basel)."},{"issue":"6","key":"4695_CR47","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nri2779","volume":"10","author":"O Soehnlein","year":"2010","unstructured":"Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010;10(6):427\u201339.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"4695_CR48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/bpa.12661","volume":"29","author":"A Arena","year":"2019","unstructured":"Arena A, Zimmer TS, van Scheppingen J, Korotkov A, Anink JJ, Muhlebner A, et al. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence. Brain Pathol. 2019;29(3):351\u201365.","journal-title":"Brain Pathol"},{"issue":"22","key":"4695_CR49","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha S, Buttari B, Panieri E, Profumo E, Saso L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 2020;25(22):5474.","journal-title":"Molecules."},{"issue":"4","key":"4695_CR50","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/antiox12040963","volume":"12","author":"C Lucchi","year":"2023","unstructured":"Lucchi C, Codeluppi A, Filaferro M, Vitale G, Rustichelli C, Avallone R, et al. Human microglia synthesize neurosteroids to cope with rotenone-induced oxidative stress. Antioxidants (Basel). 2023;12(4):963.","journal-title":"Antioxidants (Basel)."},{"issue":"5","key":"4695_CR51","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/epi.17561","volume":"64","author":"AM Costa","year":"2023","unstructured":"Costa AM, Gol M, Lucchi C, Biagini G. Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy. Epilepsia. 2023;64(5):1376\u201389.","journal-title":"Epilepsia"},{"issue":"4","key":"4695_CR52","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20150014","volume":"43","author":"JD Wardyn","year":"2015","unstructured":"Wardyn JD, Ponsford AH, Sanderson CM. Dissecting molecular cross-talk between Nrf2 and NF-kappaB response pathways. Biochem Soc Trans. 2015;43(4):621\u20136.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"4695_CR53","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.expneurol.2009.05.035","volume":"219","author":"CJ Muller","year":"2009","unstructured":"Muller CJ, Groticke I, Bankstahl M, Loscher W. Behavioral and cognitive alterations, spontaneous seizures, and neuropathology developing after a pilocarpine-induced status epilepticus in C57BL\/6 mice. Exp Neurol. 2009;219(1):284\u201397.","journal-title":"Exp Neurol"},{"key":"4695_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnbeh.2013.00036","volume":"7","author":"AS Castelhano","year":"2013","unstructured":"Castelhano AS, Cassane Gdos S, Scorza FA, Cysneiros RM. Altered anxiety-related and abnormal social behaviors in rats exposed to early life seizures. Front Behav Neurosci. 2013;7:36.","journal-title":"Front Behav Neurosci"},{"key":"4695_CR55","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fneur.2018.00476","volume":"9","author":"BL Aguilar","year":"2018","unstructured":"Aguilar BL, Malkova L, N\u2019Gouemo P, Forcelli PA. Genetically epilepsy-prone rats display anxiety-like behaviors and neuropsychiatric comorbidities of epilepsy. Front Neurol. 2018;9:476.","journal-title":"Front Neurol"},{"key":"4695_CR56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.eplepsyres.2018.02.011","volume":"143","author":"N Singh","year":"2018","unstructured":"Singh N, Vijayanti S, Saha L, Bhatia A, Banerjee D, Chakrabarti A. Neuroprotective effect of Nrf2 activator dimethyl fumarate, on the hippocampal neurons in chemical kindling model in rat. Epilepsy Res. 2018;143:98\u2013104.","journal-title":"Epilepsy Res"},{"issue":"4","key":"4695_CR57","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.23940","volume":"74","author":"M Mazzuferi","year":"2013","unstructured":"Mazzuferi M, Kumar G, van Eyll J, Danis B, Foerch P, Kaminski RM. Nrf2 defense pathway: experimental evidence for its protective role in epilepsy. Ann Neurol. 2013;74(4):560\u20138.","journal-title":"Ann Neurol"},{"issue":"37","key":"4695_CR58","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1039\/C6CC08797C","volume":"53","author":"JA Clulow","year":"2017","unstructured":"Clulow JA, Storck EM, Lanyon-Hogg T, Kalesh KA, Jones LH, Tate EW. Competition-based, quantitative chemical proteomics in breast cancer cells identifies new target profiles for sulforaphane. Chem Commun (Camb). 2017;53(37):5182\u20135.","journal-title":"Chem Commun (Camb)"},{"issue":"2","key":"4695_CR59","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1528-1157.1994.tb02446.x","volume":"35","author":"GB Raju","year":"1994","unstructured":"Raju GB, Behari M, Prasad K, Ahuja GK. Randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopherol (vitamin E) as add-on therapy in uncontrolled epilepsy. Epilepsia. 1994;35(2):368\u201372.","journal-title":"Epilepsia"},{"key":"4695_CR60","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/2277-9175.178780","volume":"5","author":"J Mehvari","year":"2016","unstructured":"Mehvari J, Motlagh FG, Najafi M, Ghazvini MR, Naeini AA, Zare M. Effects of Vitamin E on seizure frequency, electroencephalogram findings, and oxidative stress status of refractory epileptic patients. Adv Biomed Res. 2016;5:36.","journal-title":"Adv Biomed Res"},{"issue":"9","key":"4695_CR61","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/archneur.57.9.1265","volume":"57","author":"N Delanty","year":"2000","unstructured":"Delanty N, Dichter MA. Antioxidant therapy in neurologic disease. Arch Neurol. 2000;57(9):1265\u201370.","journal-title":"Arch Neurol"},{"issue":"5","key":"4695_CR62","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/jnc.13361","volume":"135","author":"C Carrasco-Pozo","year":"2015","unstructured":"Carrasco-Pozo C, Tan KN, Borges K. Sulforaphane is anticonvulsant and improves mitochondrial function. J Neurochem. 2015;135(5):932\u201342.","journal-title":"J Neurochem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04695-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04695-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04695-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T13:04:49Z","timestamp":1699448689000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04695-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4695"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04695-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3270154\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]},"assertion":[{"value":"16 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were conducted in accordance with the Association for Assessment and Accreditation of Laboratory Animal Care International and were approved by the Institutional Animal Care and Use Committee of the Hebrew University of Jerusalem (protocol code MD-20\u201316254-5 and date of approval: July 13, 2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests related to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"796"}}